FRAMINGHAM (09/24/2003) - Jim Golden, former business development manager at 454 Corp. and current member of the Bio ·IT World Editorial Advisory Board, recently accepted a new position as senior vice president and research director at drug discovery technology analyst firm Cambridge Healthtech Institute (CHI) Insights. According to Golden, his new role is to direct CHI advisors' research of new technologies in drug discovery and development.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.